Rapid malignant transformation of low-grade astrocytomas: Report of 2 cases and review of the literature

World Neurosurgery

Volumn 73, Issue 1, 2010, Pages 53-62

  Frazier, James L ^a,b   Johnson, Michael W ^a   Burger, Peter C ^a   Weingart, Jon D ^a   Quinones Hinojosa, Alfredo ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Brain Tumor Stem Cell Laboratory   (United States)

Author keywords

Glioblastoma; Grade II astrocytoma; High grade glioma; Histopathology; Low grade glioma; Malignant transformation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MOLECULAR MARKER; PROTEIN P53; TUMOR MARKER;

ADULT; ARTICLE; ASTROCYTOMA; CASE REPORT; CRANIOTOMY; DISEASE SEVERITY; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; BRAIN TUMOR; CELL TRANSFORMATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REVIEW; TIME;

ASTROCYTOMA; BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953241985     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.surneu.2009.05.010     Document Type: Article

References (49)

1. Afra D, Osztie E, Sipos L, Vitanovics D. Preoperative history and postoperative survival of supratentorial low-grade astrocytomas. Br J Neurosurg 1999;13:299-305. (Pubitemid 29304502)
2. Asari S, Makabe T, Katayama S, Itoh T, Tsuchida S, Ohmoto T. Assessment of the pathological grade of astrocytic gliomas using an MRI score. Neuroradiology 1994;36:308-10. (Pubitemid 24130047)
3. Barker FG, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997;80:936-41. (Pubitemid 27360923)
4. Batchelor TT, Betensky RA, Esposito JM, et al. Age-dependent prognostic effects of genetic alterations in glioblastoma. Clin Cancer Res 2004;10:228-33. (Pubitemid 38114184)
5. Berger MS, Deliganis AV, Dobbins J, Keles GE. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994;74:1784-91. (Pubitemid 24301834)
6. Berger MS. Surgery of low-grade gliomas-technical aspects. Clin Neurosurg 1997;44:161-80.
7. Berger MS, Rostomily RC. Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome. J Neurooncol 1997;34:85-101. (Pubitemid 27270254)
8. Bolender NF, Cromwell LD, Graves V, Margolis MT, Kerber CW, Wendling L. Interval appearance of glioblastomas not evident in previous CT examinations. J Comput Assist Tomogr 1983;7:599-603. (Pubitemid 13035942)
9. Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988;38:1371-4.
10. Claus EB, Horlacher A, Hsu L, et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 2005;103:1227-33. (Pubitemid 40328094)
11. Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 2006;106:1358-63. (Pubitemid 43363915)
12. Cohen-Gadol AA, DiLuna ML, Bannykh SI, Piepmeier JM, Spencer DD. Non-enhancing de novo glioblastoma: report of two cases. Neurosurg Rev 2004;27:281-5. (Pubitemid 39350195)
13. Earnest FT, Kelly PJ, Scheithauer BW, et al. Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 1988;166:823-7. (Pubitemid 18058950)
14. Fujimoto M, Fults DW, Thomas GA, et al. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 1989;4: 210-4.
15. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998;49:436-40. (Pubitemid 28153024)
16. Graif M, Bydder GM, Steiner RE, Niendorf P, Thomas DG, Young IR. Contrast-enhanced MR imaging of malignant brain tumors. AJNR Am J Neuroradiol 1985;6:855-62. (Pubitemid 16226994)
17. Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE. Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 1996;27:65-73. (Pubitemid 26052641)
18. Hirose Y, Aldape KD, Chang S, Lamborn K, Berger MS, Feuerstein BG. Grade II astrocytomas are subgrouped by chromosome aberrations. Cancer Genet Cytogenet 2003;142:1-7. (Pubitemid 36349255)
19. Huncharek M, Kupelnick B. Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis. Oncol Res 2000;12:107-12.
20. Johannesen TB, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a populationbased study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg 2003;99:854-62. (Pubitemid 37314921)
21. Kaye AH, Walker DG. Low grade astrocytomas: controversies in management. J Clin Neurosci 2000;7:475-83.
22. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001;95:735-45. (Pubitemid 33043344)
23. Kelly PJ. Surgical issues in the management of supratentorial lowgrade gliomas. Clin Neurosurg 1995;42:399-436.
24. Kimmelman AC, Ross DA, Liang BC. Loss of heterozygosity of chromosome 10p in human gliomas. Genomics 1996;34:250-4. (Pubitemid 26172852)
25. Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993;79:533-6. (Pubitemid 23289810)
26. Leighton C, Fisher B, Bauman G, et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 1997;15:1294-301. (Pubitemid 27167360)
27. Lote K, Egeland T, Hager B, Skullerud K, Hirschberg H. Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma. J Neurooncol 1998;40:161-70. (Pubitemid 29010169)
28. Maher EA, Brennan C, Wen PY, et al. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. Cancer Res 2006;66:11502-13. (Pubitemid 46009984)
29. Martin C, Alexander III E, Wong T, Schwartz R, Jolesz F, Black PM. Surgical treatment of low-grade gliomas in the intraoperative magnetic resonance imager. Neurosurg Focus 1998;4:e8.
30. Nagpal J, Jamoona A, Gulati ND, et al. Revisiting the role of p53 in primary and secondary glioblastomas. Anticancer Res 2006;26: 4633-9. (Pubitemid 46032092)
31. Nakamura M, Konishi N, Tsunoda S, et al. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults. Oncology 2000;58:108-16. (Pubitemid 30113861)
32. Nikas DC, Bello L, Zamani AA, Black PM. Neurosurgical considerations in supratentorial low-grade gliomas: experience with 175 patients. Neurosurg Focus 1998;4:e4.
33. Okamoto K, Ito J, Takahashi N, et al. MRI of high-grade astrocytic tumors: early appearance and evolution. Neuroradiology 2002;44: 395-402. (Pubitemid 36097189)
34. Perez-Cruet MJ, Adelman L, Anderson M, Roth PA, Ritter AM, Saris SC. CT-guided stereotactic biopsy of nonenhancing brain lesions. Stereotact Funct Neurosurg 1993;61:105-17. (Pubitemid 24263827)
35. Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF. Supratentorial low-grade astrocytomas in adults. Neurosurgery 1993;32:554-9. (Pubitemid 23099519)
36. Piepmeier JM, Christopher S, Spencer DD, et al. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgey 1996;38:872-8.
37. Pierallini A, Bonamini M, Bozzao A, et al. Supratentorial diffuse astrocytic tumours: proposal of an MRI classification. Eur Radiol 1997;7:395-9. (Pubitemid 127538637)
38. Rajan B, Pickuth D, Ashley S, et al. The management of histologically unverified presumed cerebral gliomas with radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:405-13. (Pubitemid 24020525)
39. Recht LD, Lew R, Smith TW. Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 1992;31:431-6.
40. Schmidt MH, Berger MS, Lamborn KR, et al. Repeated operations for infiltrative low-grade gliomas without intervening therapy. J Neurosurg 2003;98:1165-9. (Pubitemid 36617915)
41. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 2002;59:947-9.
42. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002;20:2267-76. (Pubitemid 34441653)
43. Shinojima N, Tada K, Shiraishi S, et al. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 2003;63:6962-70. (Pubitemid 37322983)
44. Smith JS, Tachibana I, Passe SM, et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 2001;93:1246-56. (Pubitemid 32816199)
45. Tada K, Shiraishi S, Kamiryo T, et al. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival. J Neurosurg 2001;95:651-9. (Pubitemid 33031427)
46. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 1998;64:581-7. (Pubitemid 28204142)
47. Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992;34:463-9.
48. Wiencke JK, Zheng S, Jelluma N, et al. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Oncol 2007;9:271-9. (Pubitemid 47169659)
49. Yeh SA, Ho JT, Lui CC, Huang YJ, Hsiung CY, Huang EY. Treatment outcomes and prognostic factors in patients with supratentorial lowgrade gliomas. Br J Radiol 2005;78:230-5.